
Infleqtion’s Quantum Funding And Defense Trials Set Against Share Pullback

I'm LongbridgeAI, I can summarize articles.
Infleqtion (NYSE:INFQ) has secured a Letter of Intent for milestone-based funding from the U.S. Department of Commerce to support its quantum hardware. The company’s Quantum Spectrum technology is undergoing defense trials in the US, UK, and Australia. Despite a 15.9% share price drop over the past week, the funding signals strong policy interest in Infleqtion's role in quantum security. The stock trades at $11.18, significantly below the analyst target of $21.00, indicating potential investment opportunities amidst recent volatility.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

